Salon: How a debate over two competing vaccines gripped the medical community — in 1961
Polio vaccine developed by UC's Albert Sabin embraced by world, then U.S. 60 years ago
When a polio epidemic swept across the globe for much of the 20th century, a pair of researchers raced to develop a vaccine to halt the disabling virus that could lead to paralysis.
Salon.com is out with an in-depth feature story about the efforts of Albert Sabin, a University of Cincinnati researcher, and Jonas Salk, a University of Pittsburgh scientist. Both are credited with incredible breakthroughs that ultimately led to eliminating the virus in most of the world. According to the Centers for Disease Control, no cases have originated in the United States since 1979.
Dr. Albert B. Sabin was a pre-eminent medical investigator from the University of Cincinnati and Cincinnati Children's Hospital who dedicated his life to researching the causes and cures of viruses and disease.
According to the Salon article, "the U.S. felt that Salk's vaccine had solved the polio problem and there was no need for another vaccine. So, Sabin turned to other countries for support.
"In the Soviet Union, millions of people participated in a clinical trial. With its success established, the Soviet Union began manufacturing Sabin's vaccine. It is remarkable that at the height of the Cold War an American polio vaccine got its first foothold in the communist world. Eventually, Sabin's vaccine would be approved for use in the United States in 1961 and, in a victory for Sabin, replaced Salk's vaccine in 1962."
Read the complete article
Featured image at top: Albert Sabin, MD, administers the live oral polio vaccine to children.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Follow all of UC's advanced related to the COVID-19 vaccine, or schedule a virtual visit to UC and begin picturing yourself at an institution that inspires incredible breakthroughs.
Related Stories
Biomedical engineer studying blunt and blast brain injuries
March 11, 2025
Olga Liaudanskaya, assistant professor of biomedical engineering at the University of Cincinnati, always dreamed of being a scientist. After finishing her graduate degree in materials science and engineering in Italy, she came to the United States for her postdoctoral program, where her research focused on the brain. This led her to a faculty position at UC’s College of Engineering and Applied Science. Recently, she was awarded funding from the Department of Defense for a project on the molecular mechanisms triggered by blunt and blast brain injuries.
REVIEW: CCM's 'A Midsummer Night's Dream' an 'exuberant triumph
March 10, 2025
The Cincinnati Business Courier praises UC College-Conservatory of Music's production of A Midsummer Night's Dream. Presented as part of the Opera Series on March 6-9, the production was directed by Robin Guarino and conducted by alumni guest artist William Langley.
Study: Long sentences for juveniles make reentry into society...
March 10, 2025
University of Cincinnati criminologist J.Z. Bennett has a new study that appears in the journal Criminology. The study, "Thicker Than Blood: Exploring the Importance of Carceral Bonds for Those Formerly Serving Juvenile Life Without Parole Sentences," examines the societal barriers to reentry for juveniles who served long prison sentences.